Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PD 068235

Known as: PD-068235, PD068235 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Nitro CompoundsThiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Genetic testing is ready to change the diagnostic scenario of lactose malabsorption.
We write in response to the article by Swallow ( Gut 2006; 55 :131) in which a DNA test was considered premature for diagnosing… Expand
  • figure 1
  • figure 2
Highly Cited
2004
Highly Cited
2004
Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.
This study was initiated to determine if potential PPAR gamma antagonists could block the inhibition of cell proliferation caused… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • table III
Highly Cited
2001
Highly Cited
2001
A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor γ Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated Adipocytes.
The antidiabetic thiazolidinediones, which include troglitazone and rosiglitazone, are ligands for the nuclear receptor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2001
2001
A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
The antidiabetic thiazolidinediones, which include troglitazone and rosiglitazone, are ligands for the nuclear receptor… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE